Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2013
11/21/2013US20130309770 Scaffolds and other cell-growth structures using microfluidics to culture biological samples
11/21/2013US20130309769 Identification Of Novel Cell Surface Markers For Pancreatic Progenitor Cells And Definite Endodermal Cells
11/21/2013US20130309768 Method for culturing human pluripotent stem cells
11/21/2013US20130309720 Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
11/21/2013US20130309708 Compositions and Methods Useful for Culturing Differentiable Cells
11/21/2013US20130309694 Hybridoma cell line for producing antibody for type ii collagen
11/21/2013US20130309681 Immortalization of Epithelial Cells and Methods of Use
11/21/2013US20130309662 Method of separating target cell in biological sample
11/21/2013US20130309659 Cell culturing formulation and culturing and quantification method of cd140b+ cells thereof
11/21/2013US20130309654 Method of selecting a surface chemistry for culturing a given cell line
11/21/2013US20130309653 Sperm Cell Separation System
11/21/2013US20130309652 System and Method For Automated Platelet Wash
11/21/2013US20130309236 Anti-interferon-alpha antibodies
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309213 Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppresor cells
11/21/2013US20130309209 Formation of hematopoietic progenitor cells from mesenchymal stem cells
11/21/2013US20130309206 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
11/21/2013CA2872688A1 Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna
11/20/2013EP2664674A2 Method for the production of bioproducts
11/20/2013EP2664671A1 Novel glycosyltransferase gene and use thereof
11/20/2013EP2664669A1 Treatment of pluripotent cells
11/20/2013EP2663638A1 Culture method to obtain and maintain a pure or enriched population of mammalian neural stem cells and/or neural progenitor cells that are prone to differentiate into oligodendrocyte-lineage cells in vitro
11/20/2013EP2663332A1 Enhancement of allogeneic hematopoietic stem cell transplantation
11/20/2013EP2663316A2 Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
11/20/2013EP2663313A1 Method for enhancing engraftment of haematopoetic stem cells
11/20/2013EP2439271B1 Polypeptide having d-lactate dehydrogenase activity, polynucleotide encoding the polypeptide, and process for production of d-lactic acid
11/20/2013EP2308964B1 Culturing method of mesenchymal stem cell
11/20/2013EP2272869B1 Angiopoietin-2 specific binding agents
11/20/2013EP2177611B1 Method for measurement of concentration of antigen
11/20/2013EP2041270B1 Production of glycoproteins
11/20/2013CN1989250B Tc-83-derived alphavirus vectors, particles and methods
11/20/2013CN103403165A Plant having improved resistivity or sensitivity to 4-hppd inhibitor
11/20/2013CN103403163A Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests
11/20/2013CN103403159A Method for producing virus vector for gene transfer
11/20/2013CN103403157A Phenylpyruvate reductase and method for manufacturing optically-active phenyllactic acid and 4-hydroxyl-phenyllactic acid using same enzyme
11/20/2013CN103403152A Personalized production of biologics and method for reprogramming somatic cells
11/20/2013CN103403151A Methods for enhancing the delivery of gene-transduced cells
11/20/2013CN103403150A Treatment of immune-related diseases and disorders using amnion derived adherent cells
11/20/2013CN103403149A Cell carrier, associated methods for making cell carrier and culturing cells using the same
11/20/2013CN103403148A Production of dentin, cementum and enamel by cells
11/20/2013CN103403016A Spatially modified gene expression in plants
11/20/2013CN103402533A Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom.
11/20/2013CN103397052A Endothelial progenitor cell with highly-expressed human CXCR7 (C-X-C chemokine receptor 7) gene as well as preparation method and application of endothelial progenitor cell
11/20/2013CN103397049A Plants having enhanced yield-related traits and method for making same
11/20/2013CN103397048A Method for cultivation of transgenic wheat resisting take-all and sharp eyespot and related biological materials thereof
11/20/2013CN103397045A ALK (Anaplastic Lymphoma Kinase) for gene deletion and mutant in human solid tumor
11/20/2013CN103397043A Glucanases, nucleic acids encoding same and method for making and using same
11/20/2013CN103397041A Cytolethal distending toxinand detection of campylobacter bacteria with cytolethal distending toxin as target
11/20/2013CN103397035A Application of miRNA-20a (micro ribonucleic acid-20a) serving as target in regulation of mammal host cell apoptosis
11/20/2013CN103397031A siRNA compositions and methods for potently inhibiting viral infection
11/20/2013CN103397021A Seed-preferred gene promoter from castor plant
11/20/2013CN103397009A Improved-type human coagulation factor FVII-Fc fusion protein as well as preparation method and application thereof
11/20/2013CN103397007A CeDGAT1 (Chlorella ellipsoidea Diacylglycerol Acyltransferase 1) gene and application thereof
11/20/2013CN103396998A Recombinant co-expression of vitamin k epoxide reductase subunit 1 to improve vitamin k dependent protein expression
11/20/2013CN103396997A Method for genetic diversification in gene conversion active cells
11/20/2013CN103396996A NK92 cell strain carrying TGF-betaRII and NKG2D genes, and preparation method and use thereof
11/20/2013CN103396995A Three-dimensional culture method for screening breast cancer stem cells
11/20/2013CN103396994A Ming human infiltrating type gastric cancer cell line and application thereof
11/20/2013CN103396993A Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
11/20/2013CN103396992A Culture and application of oligoclonal tumor-infiltrating lymphocytes for liver cancer
11/20/2013CN103396991A Method for rapidly and efficiently amplifying tumor infiltrating lymphocytes
11/20/2013CN103396990A Method for preparing mesenchymal stem cell
11/20/2013CN103396989A Liver progenitor cells
11/20/2013CN103396988A Separation and identification method of mouse bone marrow-derived very small embryonic-like stem cells
11/20/2013CN103396987A Totipotent stem cell culture method
11/20/2013CN103396986A Animal cell perfusion culture method, and special device and application thereof
11/20/2013CN103396985A Method for inducing differentiation of human umbilical cord mesenchymal stem cells into hepatocytes and applications
11/20/2013CN103396984A Method for preparing tissue engineering spinal cord by using ancestral cells originated from skin
11/20/2013CN103396983A Separation method of primary cells in mouse liver
11/20/2013CN103396982A Method for autocrine secretion of extracellular matrix by stem cells and induction of stem cells to become hepatocytes
11/20/2013CN103396981A In vitro culture and vitality determination method for water lily pollen
11/20/2013CN103396495A Fusion protein comprising Fc receptor binding polypeptide and antigenic polypeptide and used for mediateimmune response
11/20/2013CN103396487A Anti-IGF antibodies
11/20/2013CN103396483A Antigen associated with rheumatoid arthritis
11/20/2013CN103394115A Starch-derived absorbable medical sponge and preparation method thereof
11/20/2013CN103394079A Cancer vaccine composition
11/20/2013CN102924582B Plant-adversity-resistance related protein TaNAC67 as well as coding gene and application thereof
11/20/2013CN102876573B Mammal embryo in-vitro culture device and culture method thereof
11/20/2013CN102766595B Construction method for anabarilius grahami cardiac cell line
11/20/2013CN102702349B Bactrian camel VHH (variable domain of the heavy chain of HACbs) heavy-chain antibody for resisting foot-and-mouth disease AsiaI type viruses, preparation method and use thereof
11/20/2013CN102533635B Method for labeling mouse embryonic stem cells by using fluorescent dyes, and application thereof
11/20/2013CN102533633B Mature barley embryo tissue culture method for inhibiting sprout and rooting and culture medium used
11/20/2013CN102532309B Colloid gold test strip for detecting porcine reproductive and respiratory syndrome antibody
11/20/2013CN102505004B Extraction and fusion method for strawberry protoplast
11/20/2013CN102321566B Method for extensive amplification of cell line and mesenchymal stem cell in vitro
11/20/2013CN102296075B Gene causing paroxysmal kinesigenic dyskinesia (PKD)
11/20/2013CN102260352B Targeted interleukin fusion protein as well as preparation method thereof and application thereof
11/20/2013CN101878034B Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
11/20/2013CN101812126B Novel HLA-A2 restrictive epitope polypeptide coming from hPEBP4 protein and application thereof
11/19/2013US8588504 Technique for determining the state of a cell aggregation image processing program and image processing device using the technique, and method for producing a cell aggregation
11/19/2013US8586842 Maize variety X4K584
11/19/2013US8586833 Soybean variety XB07Z11
11/19/2013US8586832 Bacillus thuringiensis gene with Lepidopteran activity
11/19/2013US8586823 Non-dehiscent sesame IND variety Sesaco 36
11/19/2013US8586722 Methods of using tubers having genetically modified potato plant cells
11/19/2013US8586721 Antibodies specific for DKK-1 and their uses
11/19/2013US8586712 Humanized antibodies
11/19/2013US8586557 Therapy of p53 mutant colon adenocarcinoma, breast cancer and lung cancer
11/19/2013US8586360 Method of producing erythrocytes without feeder cells
11/19/2013US8586359 Compositions and methods of preparing alloreactive cytotoxic T cells
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 1827